Andrew J. Murphy is VP at REGENERON PHARMACEUTICALS, INC. (REGN). They have made 10 open-market trades across 1 company since 2020, most recently 2026-10-14.
CIK 0001796226
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 47,833 | $44.5M |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | SELL · 10b5-1 | 2026-10-14 | 2026-10-15 | $772.70 | $3.2M | +2.1% | — | — |
| REGN | SELL · 10b5-1 | 2024-08-14 | 2024-08-15 | $1153.15 | $14.7M | +2.3% | -1.9% | -31.5% |
| REGN | SELL · 10b5-1 | 2024-03-14 | 2024-03-15 | $956.44 | $11.0M | -0.4% | -7.4% | +5.8% |
| REGN | SELL · 10b5-1 | 2023-12-05 | 2023-12-06 | $817.45 | $10.6M | +1.3% | +8.7% | +14.9% |
| REGN | SELL · 10b5-1 | 2023-11-14 | 2023-11-15 | $799.15 | $10.3M | -0.1% | +7.1% | +17.3% |
| REGN | SELL | 2022-11-15 | 2022-11-16 | $727.34 | $5.2M | +0.3% | -1.4% | +2.8% |
| REGN | SELL | 2022-08-16 | 2022-08-17 | $645.55 | $4.5M | -6.8% | +11.7% | +14.6% |
| REGN | SELL | 2022-05-17 | 2022-05-18 | $663.81 | $4.5M | +0.7% | -12.0% | -1.8% |
| REGN | SELL | 2022-02-15 | 2022-02-16 | $629.36 | $4.4M | -3.4% | +9.2% | +6.2% |
| REGN | SELL | 2021-12-10 | 2021-12-10 | $666.23 | $9.3M | -5.5% | -4.9% | -3.5% |
| REGN | SELL | 2021-11-16 | 2021-11-17 | $646.99 | $9.1M | -0.9% | -3.6% | -1.9% |
| REGN | SELL | 2020-11-17 | 2020-11-18 | $542.62 | $7.1M | -1.0% | -3.9% | -7.4% |
| REGN | SELL | 2020-07-14 | 2020-07-15 | $633.48 | $3.0M | +1.4% | -2.6% | -3.3% |
| REGN | SELL | 2020-07-13 | 2020-07-15 | $626.75 | $13.9M | +1.4% | -2.6% | -3.3% |
| REGN | SELL | 2020-01-27 | 2020-01-28 | $340.96 | $5.4M | +10.3% | +24.7% | +58.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.